Sphere Fluidics

To develop technology that enables leading-edge research and accelerates biopharmaceutical discovery. We do this by providing novel single cell analysis systems for the rapid screening and characterisation of single cells. Our patented picodroplet technology is specifically designed to increase chances of finding that rare molecule or cell that can lead to a life-changing medicine.

Founded in 2010, Sphere Fluidics is an established Life Sciences company, originally spun out from the University of Cambridge. We initially developed 25 patented products – biochips and specialist chemicals – which currently assist hundreds of customers globally with their research.